Evaluation of fixed dose combination of glimepiride and metformin in patients with type 2 diabetes. Results of Russian observational study
Aim. To investigate the efficacy and safety of combined glimepiride and metformin therapy in patients with type 2 diabetes mellitus (T2DM). Materials and methods. A multi-centre, open-label, prospective, observational study was conducted. A total of 1200 patients with T2DM inadequately controlled...
Enregistré dans:
Auteurs principaux: | Natalya Vladislavovna Zaytseva, Ivona Renata Jarek-Martynova |
---|---|
Format: | article |
Langue: | EN RU |
Publié: |
Endocrinology Research Centre
2015
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/01731ff43c654097a49be8c4ae30be69 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Assessment of Clinical Experience of Triple Drug Fixed-dose Combination of Glimepiride, Metformin and Voglibose in the Management of Type 2 Diabetes Mellitus: A Retrospective Study
par: Ganapathi Bantwal, et autres
Publié: (2021) -
Efficacy and safety of glimepiride as initial treatment in Russian patients with type 2 diabetes mellitus
par: Alexander Sergeevich Ametov, et autres
Publié: (2013) -
Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus
par: Xie J, et autres
Publié: (2019) -
Modern antihyperglycemic therapy: safety and efficacy of glimepiride
par: Lyudmila Alexandrovna Ruyatkina, et autres
Publié: (2012) -
Initial investigation of efficacy and safety of a new dipeptidyl peptidase-4 inhibitor, gosogliptin, for type 2 diabetes in Russia
par: Lyudmila Viktorovna Nedosugova, et autres
Publié: (2014)